STAT

Opinion: Stem cell clinics for heart failure: buyer be wary

Patients are turning to so-called stem cell clinics that offer treatments that will supposedly reverse heart failure. They can't be sure what they are getting.
Embryonic stem cells as seen through a microscope.

We are witnessing great promise in medicine today. The vocabulary dazzles: “precision medicine,” “stem cells,” “moon shot,” and other terms that hint at exciting new possibilities. But it is also a time of great vulnerability for patients.

I’m particularly worried about stem cells or, more precisely, stem cell therapies. In theory, stem cells could help treat — or even cure — conditions ranging from cancer to heart failure. As a cardiologist, I’m especially interested in their application to the latter condition. Even though the hype far exceeds the evidence, patients are already turning to so-called stem cell clinics that claim to reverse heart failure.

So-called “pluripotential” stem cells have the ability to develop

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks